MXPA06014083A - Estructura cristalina de dipeptidil peptidasa iv y usos de la misma. - Google Patents

Estructura cristalina de dipeptidil peptidasa iv y usos de la misma.

Info

Publication number
MXPA06014083A
MXPA06014083A MXPA06014083A MXPA06014083A MXPA06014083A MX PA06014083 A MXPA06014083 A MX PA06014083A MX PA06014083 A MXPA06014083 A MX PA06014083A MX PA06014083 A MXPA06014083 A MX PA06014083A MX PA06014083 A MXPA06014083 A MX PA06014083A
Authority
MX
Mexico
Prior art keywords
dpp
computer
amino acid
seq
listed
Prior art date
Application number
MXPA06014083A
Other languages
English (en)
Spanish (es)
Inventor
Xiayang Qiu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MXPA06014083A publication Critical patent/MXPA06014083A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
MXPA06014083A 2004-06-03 2005-05-26 Estructura cristalina de dipeptidil peptidasa iv y usos de la misma. MXPA06014083A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57687704P 2004-06-03 2004-06-03
PCT/IB2005/001630 WO2005119526A1 (fr) 2004-06-03 2005-05-26 Structure cristalline de dipeptidyl peptidase iv (dpp-iv) et ses utilisations

Publications (1)

Publication Number Publication Date
MXPA06014083A true MXPA06014083A (es) 2007-02-15

Family

ID=34969993

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06014083A MXPA06014083A (es) 2004-06-03 2005-05-26 Estructura cristalina de dipeptidil peptidasa iv y usos de la misma.

Country Status (4)

Country Link
EP (1) EP1756740A1 (fr)
CA (1) CA2569095A1 (fr)
MX (1) MXPA06014083A (fr)
WO (1) WO2005119526A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5323684B2 (ja) 2006-05-04 2013-10-23 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 多形体
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
US8513187B2 (en) 2009-02-27 2013-08-20 Trustees Of Tufts College Soft protease inhibitors, and pro-soft forms thereof
US8716482B2 (en) * 2009-09-25 2014-05-06 Merck Sharp & Dohme Corp. Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
EP2366394A1 (fr) * 2010-03-17 2011-09-21 IMTM GmbH Caractérisation et validation d'inhibiteurs et de ligands de la dipeptidyl-aminopeptidase de type IV (DP IV)
EP2571876B1 (fr) 2010-05-21 2016-09-07 Merck Sharp & Dohme Corp. Composés hétérocycliques substitués à sept chaînons en tant qu'inhibiteurs de la dipeptidyl-peptidase iv pour le traitement du diabète
WO2012017391A2 (fr) * 2010-08-03 2012-02-09 Cadila Pharmaceuticals Limited Nouveaux composés en tant qu'inhibiteurs de la dpp-iv et procédé de préparation associé
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
WO2012170702A1 (fr) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulateurs du récepteur gpr119 et traitement de troubles associés à celui-ci

Also Published As

Publication number Publication date
EP1756740A1 (fr) 2007-02-28
WO2005119526A1 (fr) 2005-12-15
CA2569095A1 (fr) 2005-12-15

Similar Documents

Publication Publication Date Title
MXPA06014083A (es) Estructura cristalina de dipeptidil peptidasa iv y usos de la misma.
WO2005113762A1 (fr) Structure cristalline de proteine kinase b-$g(a) (akt-1) et utilisations correspondantes
US20050075795A1 (en) Crystal structure of 3', 5'-cyclic nucleotide phosphodiesterase (PDE1B) and uses thereof
US20080215249A1 (en) Crystallization and structure determination of beta secretase and/or beta secretase-like proteins
US20050202550A1 (en) Crystal structure of 3', 5'-cyclic nucleotide phosphodiesterase (PDE10A) and uses thereof
Kusano et al. Crystal structure of the human receptor activity‐modifying protein 1 extracellular domain
US20090125289A1 (en) Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease
US20040171019A1 (en) PIN1 peptidyl-prolyl isomerase polypeptides, their crystal structures, and use thereof for drug design
Carafoli et al. Crystal structure of the β‐chain of human hepatocyte growth factor‐like/macrophage stimulating protein
WO2011033322A2 (fr) Structure cristalline
EP1301536B1 (fr) Modulation de la fonction de la tetraspanine
EP1265927B1 (fr) Cristal
US20050085626A1 (en) Polo domain structure
US20080064052A1 (en) Crystal of a Receptor-Ligand Complex and methods of use
AU781654B2 (en) Crystallization and structure determination of staphylococcus aureus thymidylate kinase
JP2003502036A (ja) カスパーゼ−８の結晶、モデルおよび方法
US20060234293A1 (en) Polypeptide methods and means
WO2023280766A1 (fr) Structures cristallines de tyrosine kinases de récepteur alk et ltk et leurs ligands
US20080020984A1 (en) Crystal Structure of a Receptor-Ligand Complex and Methods of Use
WO2002095652A1 (fr) Polypeptide de domaine de fixation de ligands pxr/sxr de recepteur nucleaire xenobiotique humain cristallise et procedes de criblage l'utilisant
EP1618133A1 (fr) Structure cristalline de complexes du domaine kinase du recepteur du facteur de croissance endothelial vasculaire (vegfrkd) et de ligands et leurs procedes d'utilisation
MXPA06009940A (en) Crystal structure of 3',5'-cyclic nucleotide phosphodiesterase (pde10a) and uses thereof
WO2005119525A1 (fr) Structures cristallines de 11?hsd1 utilisees pour la conception de medicaments
US20050131209A1 (en) Crystallized hnf4 gamma ligand binding domain polypeptide and screening methods employing same
WO2005103241A1 (fr) Structure cristalline de 3'-5'-phosphodiesterase nucleotidique cyclique 9a (pde9a) et ses utilisations